CEO: Greater chances of more vaccine orders from the US
Danish bank Nordea sees a lot of potential in the Bavarian Nordic share following an increase in orders for the company’s smallpox vaccine from the US. The company’s CEO also sees an increased probability of more orders this year, while the share is on the rise.
The American government is steadily placing more orders for smallpox vaccines in the hands of the Danish biotech company Bavarian Nordic, a sign that even more orders could be underway this year.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
